Vitreous concentration of moxfloxacin and bacterial isolation during vitreous surgery

Vitreous concentration of moxfloxacin and bacterial isolation during vitreous surgery - Vitreous concentration of moxfloxacin and bacterial isolation

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000001942

Enrollment

Registered

2009-12-01

Start date

2007-07-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vitreoretinal diseases

Interventions

preoperative antibiotic administration (moxifloxacin) vitrectomy (20-gauge vs. 25-gauge)

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: eyes shceduled for primary vitrectomy

Exclusion criteria

Exclusion criteria: past history of vitreous surgery (vitrectomized eyes)

Design outcomes

Primary

Measure	Time frame
The rate of bacterial contamination in the vitreous samples obtained at the beginning and end of surgery	—

Secondary

Measure	Time frame
Vitreous concentration of moxifloxacin and disinfection rate of conjunctival sac	—

Countries

Japan

Contacts

Public ContactYusuke Oshima

Osaka University Medical School Department of Ophthalmology

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026